These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 7024404)

  • 1. The fixation of C3b to pneumococcal cell wall polymers as a result of activation of the alternative complement pathway.
    Hummell DS; Berninger RW; Tomasz A; Winkelstein JA
    J Immunol; 1981 Oct; 127(4):1287-9. PubMed ID: 7024404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of C3 via the alternative complement pathway results in fixation of C3b to the pneumococcal cell wall.
    Winkelstein JA; Abramovitz AS; Tomasz A
    J Immunol; 1980 May; 124(5):2502-6. PubMed ID: 7365262
    [No Abstract]   [Full Text] [Related]  

  • 3. Activation of the alternative pathway by pneumococcal cell walls.
    Winkelstein JA; Tomasz A
    J Immunol; 1977 Feb; 118(2):451-4. PubMed ID: 14211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the alternative complement pathway by pneumococcal cell wall teichoic acid.
    Winkelstein JA; Tomasz A
    J Immunol; 1978 Jan; 120(1):174-8. PubMed ID: 24071
    [No Abstract]   [Full Text] [Related]  

  • 5. Activation of human complement by Yersinia enterocolitica: ultrastructural alterations and C3b-deposition.
    Acker G; Brade V
    Zentralbl Bakteriol A; 1980 Nov; 248(2):210-28. PubMed ID: 7223121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interaction of C3b bound to pneumococci with factor H (beta 1H globulin), factor I (C3b/C4b inactivator), and properdin factor B of the human complement system.
    Brown EJ; Joiner KA; Gaither TA; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):409-15. PubMed ID: 6223077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the alternative complement pathway by pneumococcal lipoteichoic acid.
    Hummell DS; Swift AJ; Tomasz A; Winkelstein JA
    Infect Immun; 1985 Feb; 47(2):384-7. PubMed ID: 3881346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The third component of complement: covalent attachment of a radioactive sugar to the labile binding site of C3 via the alternative pathway.
    Mann J; O'Brien R; Hostetter MK; Alper CA; Rosen FS; Babior BM
    J Immunol; 1981 Jun; 126(6):2370-2. PubMed ID: 6785350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the alternative complement pathway by isolated human glomerular basement membrane.
    Williams JD; Czop JK; Abrahamson DR; Davies M; Austen KF
    J Immunol; 1984 Jul; 133(1):394-9. PubMed ID: 6373930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interactions between complement system and bacterial walls].
    Colomb MG; Bensa JC; Chesne S; Aubert B
    Bull Eur Physiopathol Respir; 1983; 19(2):131-6. PubMed ID: 6871492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional discrimination by human monocytes between their C3b receptors and their recognition units for particulate activators of the alternative complement pathway.
    Czop JK; Austen KF
    J Immunol; 1980 Jul; 125(1):124-8. PubMed ID: 7381198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The activation of the alternative complement pathway by fetal calf serum and mouse thymocytes.
    Eisenberg RA; Theofilopoulos AN; Dixon FJ
    J Immunol; 1979 May; 122(5):2045-51. PubMed ID: 87451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotaxigenesis and complement fixation by Listeria monocytogenes cell wall fractions.
    Baker LA; Campbell PA; Hollister JR
    J Immunol; 1977 Nov; 119(5):1723-6. PubMed ID: 410883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human L-ficolin recognizes phosphocholine moieties of pneumococcal teichoic acid.
    Vassal-Stermann E; Lacroix M; Gout E; Laffly E; Pedersen CM; Martin L; Amoroso A; Schmidt RR; Zähringer U; Gaboriaud C; Di Guilmi AM; Thielens NM
    J Immunol; 2014 Dec; 193(11):5699-708. PubMed ID: 25344472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the alternative complement pathway: recognition of surface structures on activators by bound C3b.
    Pangburn MK; Morrison DC; Schreiber RD; Müller-Eberhard HJ
    J Immunol; 1980 Feb; 124(2):977-82. PubMed ID: 7356723
    [No Abstract]   [Full Text] [Related]  

  • 16. Localization of complement component 3 on Streptococcus pneumoniae: anti-capsular antibody causes complement deposition on the pneumococcal capsule.
    Brown EJ; Joiner KA; Cole RM; Berger M
    Infect Immun; 1983 Jan; 39(1):403-9. PubMed ID: 6822421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgG on mouse erythrocytes augments activation of the human alternative complement pathway by enhancing deposition of C3b.
    Moore FD; Fearon DT; Austen KF
    J Immunol; 1981 May; 126(5):1805-9. PubMed ID: 6908606
    [No Abstract]   [Full Text] [Related]  

  • 18. Solubilization of antigen-antibody complexes: a new function of complement as a regulator of immune reactions.
    Takahashi M; Takahashi S; Hirose S
    Prog Allergy; 1980; 27():134-66. PubMed ID: 6986046
    [No Abstract]   [Full Text] [Related]  

  • 19. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
    Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
    Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of complement inactivation by glycoprotein C of herpes simplex virus.
    Kostavasili I; Sahu A; Friedman HM; Eisenberg RJ; Cohen GH; Lambris JD
    J Immunol; 1997 Feb; 158(4):1763-71. PubMed ID: 9029114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.